MiMedx Group, Inc.
MDXG
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniquesā¦ read more
Healthcare
Biotechnology
17 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$6.31
Price-2.02%
-$0.13
1Y
Price
Market Cap
$934.525m
Small
Price/Earnings 3y Avg5y Avg
23.4x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+25.4%
EBITDA Margin+14.7%
Net Profit Margin+22.3%
Free Cash Flow Margin+25.4%
EBITDA Margin+14.7%
Net Profit Margin+22.3%
Free Cash Flow MarginRevenue
$393.442m
+12.8%
1y CAGR+13.8%
3y CAGR+13.0%
5y CAGREarnings
$40.827m
-3.7%
1y CAGR+94.2%
3y CAGR+34.3%
5y CAGREPS
$0.27
-3.6%
1y CAGR+70.3%
3y CAGR+2.7%
5y CAGRBook Value
$238.946m
$318.988m
Assets$80.042m
Liabilities$18.214m
DebtDebt to Assets
5.7%
0.3x
Debt to EBITDAFree Cash Flow
$63.533m
-1.5%
1y CAGR+128.8%
3y CAGR+28.3%
5y CAGRNo items found.
Press Releases
Statements and updates from the company